SPOTLIGHT -
News
Article
Author(s):
Our March CME reviews the principles and applications of invasive and noninvasive neuromodulation techniques for the treatment of mood disorders. Here are 5 key takeaways.
AXS-05 Demonstrates Efficacy and Manageable Adverse Effects in Major Depressive Disorder Treatment
Blue Light Blockers: A Behavior Therapy for Mania
CYB003 for the Adjunctive Treatment of Major Depressive Disorder
Treating ‘Morally Objectionable’ Patients
Positive Results in Phase 2b Trial of Psychedelic Agent GH001 for Treatment-Resistant Depression
The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review